Edmund K. Waller,Cynthia R. Giver,Sravanti Rangaraju
申请号：
US14561275
公开号：
US20150158925A1
申请日:
2014.12.05
申请国别(地区):
US
年份:
2015
代理人:
摘要：
This disclosure relates to the use of drugs to prevent graft versus host disease (GVHD) in a subject after, before, or during a hematopoietic stem cell transplant. In certain embodiments, the drugs are antagonist of vasoactive intestinal peptide signaling. In certain embodiments, the subject has a blood or bone marrow cancer or condition.
